Cargando…

Real-Life Effectiveness of Vismodegib in Patients with Metastatic and Advanced Basal Cell Carcinoma: Characterization of Adverse Events and Assessment of Health-Related Quality of Life using the Dermatology Life Quality Index (DLQI) Test

INTRODUCTION: Non-melanoma skin cancer (NMSC) is the most common type of human tumor, with an estimated five million new cases each year. NMSC has been described as having a major impact on the health-related quality of life of the patient. Vismodegib is a hedgehog pathway inhibitor therapy for pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Villani, Alessia, Fabbrocini, Gabriella, Cappello, Milena, Costa, Claudia, Scalvenzi, Massimiliano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704212/ https://www.ncbi.nlm.nih.gov/pubmed/31165365 http://dx.doi.org/10.1007/s13555-019-0303-4

Ejemplares similares

Long-Term Efficacy of Vismodegib After its Withdrawal and Patients’ Health-Related Quality of Life Using the Dermatology Life Quality Index (DLQI)
por: Villani, Alessia, et al.
Publicado: (2019)

Vismodegib treatment in advanced basal cell carcinomas: Real‐life experience
por: Villani, Alessia, et al.
Publicado: (2021)

Low-Dose Vismodegib as Maintenance Therapy After Locally Advanced Basal Cell Carcinoma Complete Remission: High Efficacy with Minimal Toxicity
por: Scalvenzi, Massimiliano, et al.
Publicado: (2020)

Reflectance Confocal Microscopy Identification of Subclinical Basal Cell Carcinoma after Vismodegib Treatment: Report of a Case
por: Villani, Alessia, et al.
Publicado: (2021)

Rasch analysis holds no brief for the use of the Dermatology Life Quality Index (DLQI) in Chinese neurodermatitis patients
por: Liu, Yale, et al.
Publicado: (2016)

A Rasch model analysis of two interpretations of ‘not relevant’ responses on the Dermatology Life Quality Index (DLQI)
por: Rencz, Fanni, et al.
Publicado: (2021)

Biologics Can Significantly Improve Dermatology Life Quality Index (DLQI) in Psoriatic Patients: A Systematic Review
por: de Ruiter, Chanel Claudine, et al.
Publicado: (2022)

Sonidegib treatment in patients with locally advanced basal cell carcinoma
por: Villani, Alessia, et al.
Publicado: (2022)

Minimal Important Difference (MID) of the Dermatology Life Quality Index (DLQI): Results from patients with chronic idiopathic urticaria
por: Shikiar, Richard, et al.
Publicado: (2005)

Sonidegib‐induced muscle spasms in the treatment of basal cell carcinoma: Strategies to adopt
por: Villani, Alessia, et al.
Publicado: (2022)

Psychometric characteristics of DLQI-BRA and Skindex-16 to measure the impact of dermatological diseases on quality of life in Brazilian patients
por: Meneguin, Silmara, et al.
Publicado: (2021)

Sonidegib: Safety and Efficacy in Treatment of Advanced Basal Cell Carcinoma
por: Villani, Alessia, et al.
Publicado: (2020)

New Emerging Treatment Options for Advanced Basal Cell Carcinoma and Squamous Cell Carcinoma
por: Villani, Alessia, et al.
Publicado: (2022)

Systemic hedgehog inhibitors to treat locally advanced basal cell carcinomas of the head–neck region: A retrospective study
por: Villani, Alessia, et al.
Publicado: (2021)

Sonidegib with and Without Adjunctive Treatment for Locally Advanced Basal Cell Carcinomas
por: Villani, Alessia, et al.
Publicado: (2022)

Patients with advanced basal cell carcinomas in treatment with sonic hedgehog inhibitors during the coronavirus disease 2019 (COVID-19) period: Management and adherence to treatment
por: Villani, Alessia, et al.
Publicado: (2020)

A Quality of Life Study in Patients with Leprosy Using DLQI and WHOQOL-BREF Questionnaires
por: Tare, Dakshata A, et al.
Publicado: (2021)

The Efficacy of Sonidegib in Treating Locally Advanced Basal Cell Carcinoma Involving the Periocular Area
por: Villani, Alessia, et al.
Publicado: (2023)

Comparison of Three Quality of Life Instruments in Lymphatic Filariasis: DLQI, WHODAS 2.0, and LFSQQ
por: Thomas, Cristina, et al.
Publicado: (2014)

Long‐term efficacy of telemedicine for patients with locally advanced basal cell carcinoma during COVID‐19 pandemic
por: Villani, Alessia, et al.
Publicado: (2022)

Psoriasis: correlation between severity index (PASI) and quality of life index (DLQI) in patients assessed before and after systemic treatment()
por: da Silva, Maria Flávia Pereira, et al.
Publicado: (2013)

Mapping Dermatology Life Quality Index (DLQI) scores to EQ-5D utility scores using data of patients with atopic dermatitis from the National Health and Wellness Study
por: Vilsbøll, Andreas Westh, et al.
Publicado: (2020)

“DLQI Seems to be ‘Action’, and Skindex-29 Seems to be ‘Emotion’”: Qualitative Study of the Perceptions of Patients with Psoriasis or Eczema on Two Common Dermatology-specific Quality of Life Measures
por: Paudyal, Priyamvada, et al.
Publicado: (2020)

Looking into a Better Future: Novel Therapies for Metastatic Melanoma
por: Villani, Alessia, et al.
Publicado: (2021)

Melanoma Screening Days During the Coronavirus Disease 2019 (COVID-19) Pandemic: Strategies to Adopt
por: Villani, Alessia, et al.
Publicado: (2020)

Reflectance confocal microscopy for Kaposi's sarcoma treatment monitoring after intralesional vincristine chemotherapy
por: Villani, Alessia, et al.
Publicado: (2022)

Dermatology Life Quality Index does not Reflect Quality of Life Status of Indian Vitiligo Patients
por: Narahari, S R, et al.
Publicado: (2016)

Impact of Childhood Psoriasis on Caregivers’ Quality of Life, Measured with Family Dermatology Life Quality Index
por: ZYCHOWSKA, Magdalena, et al.
Publicado: (2020)

Investigational agents in metastatic basal cell carcinoma: focus on vismodegib
por: Batty, Nicolas, et al.
Publicado: (2012)

Effect of Topical Steroid-Dependent Facial Dermatitis on Quality of Life: A Hospital-Based Cross-Sectional Study Using DLQI
por: Rastogi, Madhur K, et al.
Publicado: (2019)

Using the Dermatology Life Quality Index to Assess How Breast Radiodermatitis Affects Patients’ Quality of Life
por: Beamer, Laura Curr, et al.
Publicado: (2019)

Cutaneous Bowen’s Disease: an Analysis of 182 Cases according To Age, Sex, and Anatomical Site from an Italian Center
por: Scalvenzi, Massimiliano, et al.
Publicado: (2019)

Alopecia Areata-Quality of Life Index Questionnaire (Reliability and Validity of the Persian Version) in Comparison to Dermatology Life Quality Index
por: Nasimi, Maryam, et al.
Publicado: (2020)

Health Related Quality of Life of Rosacea Patients in China Assessed by Dermatology Life Quality Index and Willingness to Pay
por: Huang, Yaqun, et al.
Publicado: (2022)

Merkel Cell Carcinoma: Therapeutic Update and Emerging Therapies
por: Villani, Alessia, et al.
Publicado: (2019)

Long‐term results of teledermatology for acne patients during COVID‐19 pandemic
por: Villani, Alessia, et al.
Publicado: (2022)

Understanding the impact of acne vulgaris and associated psychological distress on self-esteem and quality of life via regression modeling with CADI, DLQI, and WHOQoL
por: Morshed, A. S. M., et al.
Publicado: (2023)

Giant basal cell carcinoma of the vulva successfully treated with Sonidegib
por: Camela, Elisa, et al.
Publicado: (2022)

Community Knowledge About the Use, Reuse, Disinfection and Disposal of Masks and Filtering Facepiece Respirators: Results of a Study Conducted in a Dermatology Clinic at the University of Naples in Italy
por: Scalvenzi, Massimiliano, et al.
Publicado: (2020)

Dermatology Life Quality Index and disease coping strategies in psoriasis patients
por: Liluashvili, Sopiko, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_09130ndr66g045tgpic0lmfpuq